form
liquid
reaction suitability
reagent type: reductant
concentration
1.0 M in hexanes
density
0.701 g/mL at 25 °C
SMILES string
CC(C)C[AlH]CC(C)C
InChI
1S/2C4H9.Al.H/c2*1-4(2)3;;/h2*4H,1H2,2-3H3;;
InChI key
AZWXAPCAJCYGIA-UHFFFAOYSA-N
Application
用于Pd催化的仲烷基溴的还原脱溴过程。过苄基化呋喃糖苷的O-脱苄基和开环。方便从 ZrCp2Cl2 和DIBAL-H原位生成 HZrCp2Cl。
Other Notes
建议使用弯通式隔垫入口接头 Z118206 或直通式隔垫入口接头 Z118141（6mm 内径入口）或直通式隔垫入口接头 Z118192（13mm 内径入口）。
Still not finding the right product?
Explore all of our products under 氢化二异丁基铝 溶液
signalword
Danger
target_organs
Central nervous system, Nervous system
supp_hazards
存储类别
4.2 - Pyrophoric and self-heating hazardous materials
wgk
WGK 3
flash_point_f
-9.4 °F
flash_point_c
-23 °C
Hazard Classifications
Aquatic Chronic 2 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Pyr. Liq. 1 - Repr. 2 - Skin Corr. 1B - STOT RE 2 Inhalation - STOT SE 3 - Water-react. 1
法规信息
新产品
此项目有
Takashi Tomioka et al.
The Journal of organic chemistry, 76(11), 4669-4674 (2011-04-30)
Stepwise, selective DIBAL reduction of the acetonide diester derived from tartaric acid followed by the Horner-Emmons reaction effectively provided desymmetrized hydroxy mono-olefination products in a one-pot operation.
[The reduction of prostaglandin intermediate with diisobutylaluminium hydride].
Z Y Liu et al.
Yao xue xue bao = Acta pharmaceutica Sinica, 17(4), 296-298 (1982-04-01)
K Hirota et al.
Nucleic acids symposium series, (34)(34), 15-16 (1995-01-01)
It is reported that the diisobutylaluminum hydride (DIBALH) reduction of inosine and adenosine derivatives (1a and 1d) causes cleavage of the ribose moiety to give the corresponding 9-ribitylhypoxanthine (2a) and 9-ribityladenine (2d), respectively. The substitution effect of purine nucleosides on